The Journey of Commitment to Ultra-Rare Disease Patients: A Supportive Business ModelByChris Adams, PhD, MBAAugust 5th 2019Over the last 5 years, more than 4000 FDA-regulated clinical trials were initiated worldwide for rare disease treatments.